August 29, 2014 6:07 AM ET

Capital Markets

Company Overview of Novo A/S

Company Overview

Novo A/S is a private equity and venture capital arm of The Novo Nordisk Foundation specializing in direct and secondary direct investments. Within direct, it seeks to make private equity and venture capital investments in development stage companies in the form of seed, start up, early venture, mid venture, late venture, growth equity, mature, later stage, and mezzanine investments. It also provides pre-seed grants for early stage projects. The firm seeks to invest in biotechnology, healthcare, and life sciences companies with a focus on investments in products for diagnosis, control, treatment, and prevention of disease; development and application of biotechnology; instruments and medical...

Tuborg Havnevej 19

Hellerup,  DK-2900

Denmark

Founded in 1999

Phone:

45 35 27 65 00

Fax:

45 35 27 65 10

Key Executives for Novo A/S

Chief Executive Officer
Age: 55
Chief Financial Officer
Age: 67
Managing Partner
Age: 62
Senior Partner
Age: 60
Senior Partner
Age: 58
Compensation as of Fiscal Year 2014.

Novo A/S Key Developments

Novo A/S Presents at 2014 Asia Biotech Invest Conference, Jun-03-2014 through Jun-05-2014

Novo A/S Presents at 2014 Asia Biotech Invest Conference, Jun-03-2014 through Jun-05-2014. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Presentation Date & Speakers: Jun-04-2014, Eric Shiozaki, Principal. Jun-05-2014, Eric Shiozaki, Principal.

Novo A/S Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-13-2014 11:50 AM

Novo A/S Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-13-2014 11:50 AM. Venue: London, United Kingdom. Speakers: Martin W. Edwards, Senior Partner.

Novo A/S Presents at Sachs Annual Biotech in Europe Investor Forum, Sep-30-2013 12:10 PM

Novo A/S Presents at Sachs Annual Biotech in Europe Investor Forum, Sep-30-2013 12:10 PM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152, Zurich, Switzerland. Speakers: Nanna Luneborg, Investment Director, Novo Seeds.

Similar Private Companies By Industry

Company Name Region
Spf. 14 Europe
KPMG Statsautoriseret Revisionspartnerselskab, Investment Banking Arm Europe
aa ejendomme 2 Ap Europe
Catella Corporate Finance A/S Europe
Kirstein Holding A/S Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 15, 2014
Sonion A/S
Merger/Acquisition
July 11, 2014
Archimedes Pharma Limited
Merger/Acquisition
June 17, 2014
ProteinSimple
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novo A/S, please visit www.novo.dk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.